A Study of Abemaciclib (LY2835219) in Participants With Breast Cancer

NCT02763566 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

463

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Abemaciclib
DRUG: Anastrozole
DRUG: Letrozole
DRUG: Placebo
DRUG: Fulvestrant

Sponsor

Eli Lilly and Company